Paper II — 2025 March (Supplementary) (2010 Scheme) — Q8
2 min read
Paper II
2025 March (Supplementary) (2010 Scheme)
Question
Metoclopramide in vomiting.
Q81 marksShort Answers
Answer
Metoclopramide is a dopamine D2 receptor antagonist with prokinetic properties. It exerts its antiemetic effect through central D2 blockade at the chemoreceptor trigger zone (the same mechanism as other D2-antagonist antiemetics), while its additional 5-HT4 agonist/prokinetic action increases gastric emptying and lower esophageal sphincter tone — making it particularly useful for vomiting associated with delayed gastric emptying (diabetic gastroparesis, post-operative ileus) and GERD-related nausea, where a purely central antiemetic would not address the underlying motility component.